J. Goldman & Co LP - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q2 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2020$326,000
-40.5%
269,235
-22.4%
0.02%
-56.8%
Q3 2020$548,000
-3.9%
347,046
-23.8%
0.04%
+5.7%
Q2 2020$570,000
-59.0%
455,678
-65.3%
0.04%
-79.2%
Q1 2020$1,391,000
-78.6%
1,312,690
-51.1%
0.17%
-63.9%
Q4 2019$6,496,000
+43.8%
2,684,481
+115.7%
0.47%
+37.5%
Q3 2019$4,517,000
+3.0%
1,244,438
-26.2%
0.34%
+11.5%
Q2 2019$4,386,000
-54.6%
1,686,787
-14.9%
0.30%
-44.1%
Q1 2019$9,655,000
+54.6%
1,982,551
+21.0%
0.54%
+13.1%
Q4 2018$6,245,000
+245.2%
1,639,062
+494.3%
0.48%
+281.7%
Q3 2018$1,809,000
+23.6%
275,816
+17.5%
0.13%
+65.8%
Q2 2018$1,464,000
-59.8%
234,649
-68.6%
0.08%
-51.0%
Q1 2018$3,643,000
-58.3%
748,112
-48.3%
0.16%
-66.2%
Q4 2017$8,742,000
+102.9%
1,447,394
+77.7%
0.46%
+111.5%
Q3 2017$4,309,000
-13.2%
814,500
-13.6%
0.22%
-19.3%
Q2 2017$4,967,000
+515.5%
942,400
+740.6%
0.27%
+572.5%
Q1 2017$807,000
-78.6%
112,114
-82.8%
0.04%
-84.0%
Q4 2016$3,770,000
-21.2%
653,350
-7.0%
0.25%
-7.4%
Q3 2016$4,783,000
+237.5%
702,400
+190.4%
0.27%
+123.1%
Q3 2015$1,417,000241,8650.12%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders